Journal: Frontiers in Endocrinology
Article Title: Mast cell promotes obesity by activating microglia in hypothalamus
doi: 10.3389/fendo.2025.1544213
Figure Lengend Snippet: Pharmacological stabilization of mast cells in brain improves metabolic homeostasis in HFD-fed mice. (A) Body weight and body weight changes (B) in control and cromolyn sodium-injected mice, n = 8 per group. DEXA images (C) and fat mass (D) of control and cromolyn sodium-injected mice. Representative H&E-stained images of adipose tissue (E) and average adipocyte size (F) , n = 8 per group. (G, H) Representative H&E-stained liver images and relative lipid droplet area, n = 8 per group. (I, J) Glucose tolerance test (GTT) and area under the curve (AUC), n = 8 per group. (K-N) Food intake and total energy expenditure in both groups of mice, n = 8 per group. ns, not significant. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, two-tailed Student’s t-test (D, H, J, L, M, N) , two-way ANOVA with Bonferroni’s post hoc test (A, I, K) .
Article Snippet: For cromolyn sodium treatment, HFD-fed mice implanted with a guide cannula targeting the lateral ventricle were administered cromolyn sodium (MCE, HY-B0320A) intracerebroventricularly (i.c.v.) daily at a dose of 10 µg, immediately before the light was turned off.
Techniques: Control, Injection, Staining, Two Tailed Test